Original Source(s)
Related Content
FDA Clears Avulux Migraine Lenses
FDA De Novo authorization establishes a new device classification for lenses designed to reduce migraine-associated light sensitivity
September 15, 2026
-
2 min
Visual Snow Challenges Diagnosis
A case highlights persistent visual symptoms despite normal testing and suggests a neurofunctional origin.
April 1, 2026
-
3 min
MRI May Define Two Distinct Migraine Phenotypes
Patients with greater migraine burden showed widespread connectivity changes and lower cortical volume.
May 21, 2026
-
3 min